US-based biopharmaceutical services company Quintiles has further expanded its Global Laboratories network by opening a new, expanded central laboratory in Centurion, South Africa.
The 7,500 sq ft facility lab offers enhanced testing capabilities, spanning tuberculosis, microbiology services, HIV, immunofluorescence and flow cytometry, to address a wider range of studies across multiple therapeutic areas throughout sub-Saharan Africa, Quintiles said.
The company has been operating in South Africa since 1996 and has since established bases in Ghana, Kenya and Benin.
Like the other central labs in Quintiles’ global network, which includes wholly owned facilities in the US, Europe, South Africa, India, China, Singapore and Japan, as well as “tightly coordinated” affiliate labs in Argentina and Brazil, the expanded unit in Centurion is accredited by the College of American Pathologists (CAP).
“This facility has the latest technology and equipment which, combined with our rigorous CAP-accredited standards and practices, will speed the delivery of clean, reliable and comparable data to customers and investigators,” commented Graham Murray, head of Quintiles Global Laboratories in the Europe, Middle East and Africa.
